To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

The Use of Various Antithrombotic Agents for Venous Thromboembolism Prophylaxis After TKA

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2023

The Use of Various Antithrombotic Agents for Venous Thromboembolism Prophylaxis After TKA

Vol: 303| Issue: 4| Number:5| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study.

BMC Musculoskelet Disord . 2023 Jan 4;24(1):5.

Contributing Authors:
LB Zhou CC Wang LT Zhang T Wu GQ Zhang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and eighty patients undergoing primary unilateral total knee arthroplasty were randomized to receive either rivaroxaban (n=60), dalteparin sodium (n=60), or aspirin (n=60) once a day for 30 days. The primary outcomes of interest were drainage volume and thrombotic complication rates. Secondary outcomes of interest included platelet count, blood volume, transfusion rate, intraoperative ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.